MedTrace Logo

Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)

NCT02742922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 901

Last updated 2023-05-19

No results posted yet for this study

Summary

To evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

Conditions

  • Self Harm

Interventions

BEHAVIORAL

Culturally adapted therapy (C-MAP)

C-MAP is a brief problem focused therapy, comprising of six sessions delivered within three months. C-MAP is a manual assisted intervention based on the principles of CBT .In this intervention there is an evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking and relapse prevention strategies.

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Dow University of Health Sciences

    collaborator OTHER

  • Karachi Medical and Dental College

    collaborator OTHER

  • Services Hospital, Lahore

    collaborator OTHER_GOV

  • Peshawar Medical College

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husian, MD · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-27
Primary Completion
2019-07-30
Completion
2019-10-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02742922 on ClinicalTrials.gov